Acumen Selects Two Enhanced Brain Delivery Candidates for Alzheimer’s

Acumen Pharmaceuticals has selected two development candidates for its Enhanced Brain Delivery (EBD) program, advancing a new generation of Alzheimer’s... Read More

The post Acumen Selects Two Enhanced Brain Delivery Candidates for Alzheimer’s appeared first on citybiz.